Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€36.70

€36.70

-1.410%
-0.52
-1.410%
€52.50

€52.50

 
22:26 / Tradegate WKN: A3ENQ5 / Name: Schott Pharma & Co. Kgaa / Stock / ? /
Latest predictions
€59.00
21.03.24
-11.35%
buy
€46.00
29.02.24
-13.44%
buy
06.10.23
19.23%
buy
Best running prediction
-
06.10.23
19.23%
buy
Your prediction

Schott Pharma AG & Co. Kgaa Stock

We can see a decrease in the price for Schott Pharma AG & Co. Kgaa. Compared to yesterday it has lost -€0.520 (-1.410%).
Currently there is a rather positive sentiment for Schott Pharma AG & Co. Kgaa with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 52 € shows a positive potential of 41.69% compared to the current price of 36.7 € for Schott Pharma AG & Co. Kgaa.

Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda